Gilead Sciences (GILD)
$170.68 +3.06% Close Oct 30, 2026 Live
Gilead Sciences stock today
Gilead Sciences closed at $170.68 on October 30, 2026, up 3.06% on the day. Over the past year it returned +47.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $212 billion.
$120.00$140.00$160.00
NovJan 2026MarMayJulSep
| Period | GILD | S&P 500 (SPY) |
|---|---|---|
| 1 month | +14.5% | -0.9% |
| 3 months | +30.7% | +2.1% |
| Year to date | +41.6% | +11.7% |
| 1 year | +47.7% | +12.4% |
| 3 years | +141.2% | +88.5% |
| 5 years | +214.1% | +76.0% |
Key statistics
- Market value
- $212B
- Forward P/E
- 35.9
- Price / sales
- 6.8
- Dividend yield
- 1.90%
- 52-week range
- $118.15 to $170.68
About Gilead Sciences
Biopharmaceutical company developing antiviral and immunology therapies.
Sector: Health Care · Industry: Biotechnology
More on Gilead Sciences
- Financials: revenue, earnings and segmentsRevenue +2% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $3,292 today
No forecast, no recommendation. This page describes Gilead Sciences from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.